Effects of menthol on nicotine pharmacokinetic, pharmacology and dependence in mice

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Alsharari, Shakir D ^a,b   King, Justin R ^c   Nordman, Jacob C ^c   Muldoon, Pretal P ^b   Jackson, Asti ^b   Zhu, Andy Z X ^d   Tyndale, Rachel F ^d   Kabbani, Nadine ^c   Damaj, M Imad ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MECAMYLAMINE; MENTHOL; NICOTINE; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2; NICOTINIC RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; BRAIN LEVEL; CLEARANCE; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; HYPOTHERMIA; MALE; MOUSE; NICOTINE BLOOD LEVEL; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOKING CESSATION; TOBACCO DEPENDENCE; WESTERN BLOTTING; ANIMAL; BLOOD; BODY TEMPERATURE; BRAIN; COMPLICATION; DRUG EFFECTS; FEMALE; HYPERALGESIA; INDUCED HYPOTHERMIA; INSTITUTE FOR CANCER RESEARCH MOUSE; MAZE TEST; METABOLISM; NOCICEPTION; TIME FACTOR; TOBACCO USE DISORDER; WITHDRAWAL SYNDROME;

ANIMALS; BODY TEMPERATURE; BRAIN; FEMALE; HYPERALGESIA; HYPOTHERMIA, INDUCED; MALE; MAZE LEARNING; MENTHOL; MICE, INBRED ICR; NICOTINE; NOCICEPTION; RECEPTORS, NICOTINIC; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TOBACCO USE DISORDER;

EID: 84944754737     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137070     Document Type: Article

References (24)

1. Benowitz NL, Herrera B, Jacob P III. Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther. 2004; 310(3), 1208-1215. PMID: 15084646
2. Williams JM, Gandhi KK, Steinberg ML, Foulds J, Ziedonis DM, Benowitz NL. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob Res. 2007 Aug; 9(8):873-81. PMID: 17654300
3. Gandhi KK, Foulds J, Steinberg MB, Lu SE, Williams JM. Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int J Clin Pract. 2009; 63(3):360-7. doi: 10.1111/j.1742-1241.2008.01969.x PMID: 19222622
4. Okuyemi KS, Faseru B, Sanderson Cox L, Bronars CA, Ahluwalia JS. Relationship between menthol cigarettes and smoking cessation among African American light smokers. Addiction. 2007; 102 (12):1979-86. PMID: 17916223
5. Pletchr MJ, Hulley BJ, Houston T, Kiefe CI, Benowitz N, Sidney S. Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arch Intern Med. 2006 Sep 25; 166(17):1915-22. PMID: 17000950
6. Dessirier JM, O'Mahony M, Carstens E. Oral irritant properties of menthol: sensitizing and desensitizing effects of repeated application and cross-desensitization to nicotine. Physiol Behav. 2001 May; 73(1-2):25-36. PMID: 11399291
7. Ruskin DN, Anand R, LaHoste GJ. Chronic menthol attenuates the effect of nicotine on body temperature in adolescent rats. Nicotine Tob Res. 2008 Dec; 10(12):1753-9. doi: 10.1080/14622200802443734 PMID: 19023826
8. Willis DN, Liu B, Ha MA, Jordt SE, Morris JB. Menthol attenuates respiratory irritation responses to multiple cigarette smoke irritants. FASEB J. 2011 Dec; 25(12):4434-44. doi: 10.1096/fj.11-188383 PMID: 21903934
9. Hans M, Wilhelm M, Swandulla D. Menthol suppresses nicotinic acetylcholine receptor functioning in sensory neurons via allosteric modulation. Chem Senses. 2012; 37(5):463-9. doi: 10.1093/chemse/bjr128 PMID: 22281529
10. Hogg RC, Raggenbass M, Bertrand D. Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol. 2003; 147:1-46. PMID: 12783266
11. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev. 2009; 89(1):73-120. doi: 10.1152/physrev.00015.2008 Review PMID: 19126755
12. Brody AL, Mukhin AG, La Charite J, Ta K, Farahi J, Sugar CA, et al. Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers. Int J Neuropsychopharmacol. 2013 Jun; 16(5):957-66. doi: 10.1017/S1461145712001022 PMID: 23171716
13. Isola R, Vogelsberg V, Wemlinger TA, Neff NH, Hadjiconstantinou M. Nicotine abstinence in the mouse. Brain Res. 1999; 850(1-2):189-96. PMID: 10629764
14. Jackson KJ, Martin BR, Changeux JP, Damaj MI. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther. 2008 Apr; 325 (1):302-12. doi: 10.1124/jpet.107.132977 PMID: 18184829
15. Kabbani N, Woll MP, Levenson R, Lindstrom JM, Changeux JP. Intracellular complexes of the beta2 subunit of the nicotinic acetylcholine receptor in brain identified by proteomics. Proc Natl Acad Sci. 2007 Dec 18; 104(51):20570-5. PMID: 18077321
16. Govind AP, Vezina P, Green WN. Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol. 2009 Oct 1; 78(7):756-65. doi: 10.1016/j.bcp.2009.06.011 PMID: 19540212
17. MacDougall JM, Fandrick K, Zhang X, Serafin SV, Cashman JR. Inhibition of human liver microsomal (S)-nicotine oxidation by (-)-menthol and analogues. Chem Res Toxicol. 2003; 16(8):988-93. PMID: 12924926
18. Kramlinger V, von Weymarn LB, Murphy SE. Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, ß-nicotyrine and menthol. Chem Biol Interact. 2012; 197(2-3):87-92. doi: 10.1016/j.cbi.2012.03.009 PMID: 22486895
19. Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther. 2008; 83(4), 531-541. doi: 10.1038/clpt.2008.3 PMID: 18305452
20. Bagdas D, Muldoon PP, Zhu AZ, Tyndale RF, Damaj MI. Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice. Neuropharmacology. 2014 Oct; 85:67-72. PMID: 24859605
21. Ashoor A, Nordman JC, Veltri D, Yang KH, Al Kury L, Shuba Y, et al. Menthol binding and inhibition of α7-nicotinic acetylcholine receptors. PLoS One. 2013 Jul 23; 8(7):e67674. doi: 10.1371/journal.pone. 0067674 PMID: 23935840
22. Pan R, Tian Y, Gao R, Li H, Zhao X, Barrett JE, et al. Central mechanisms of menthol-induced analgesia. J Pharmacol Exp Ther. 2012 Dec; 343(3):661-72. doi: 10.1124/jpet.112.196717 PMID: 22951274
23. Cosgrove KP, Batis J, Bois F, Maciejewski PK, Esterlis I, Kloczynski T, et al. beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Arch Gen Psychiatry. 2009 Jun; 66(6):666-76. doi: 10.1001/archgenpsychiatry.2009.41 PMID: 19487632
24. Turner JR, Castellano LM, Blendy JA. Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. Nicotine Tob Res. 2011 Jan; 13 (1):41-6. doi: 10.1093/ntr/ntq206 PMID: 21097981